Frequent long-distance plant colonization in the changing Arctic

The ability of species to track their ecological niche after climate change is a major source of uncertainty in predicting their future distribution. By analyzing DNA fingerprinting (amplified fragment-length polymorphism) of nine plant species, we show that long-distance colonization of a remote arctic archipelago, Svalbard, has occurred repeatedly and from several source regions. Propagules are likely carried by wind and drifting sea ice. The genetic effect of restricted colonization was strongly correlated with the temperature requirements of the species, indicating that establishment limits distribution more than dispersal. Thus, it may be appropriate to assume unlimited dispersal when predicting long-term range shifts in the Arctic.     

The paradox of keystone species persecuted as pests: A call for the conservation of abundant small mammals in their native range

Small mammals, such as European rabbits (Oryctolagus cuniculus), plateau pikas (Ochotona curzoniae) and prairie dogs (Cynomys spp.), traditionally have been perceived as pests and targeted for control within their native ranges, where they perform essential ecosystem roles and are considered keystone species. These species can reach high densities, and have been subjected to eradication campaigns because of their putative negative impact on natural habitats and agriculture and their competition with livestock for forage. Eradication programmes have been a main factor causing sharp declines of these species in their natural ranges. Paradoxically, they are keystone species where they are abundant enough to be perceived as pests. The term “pest” is usually a social perception that is rarely supported by scientific data, whereas there is considerable scientific evidence of the key ecological roles played by these species. We call for the conservation of these species and present a conceptual model regarding the management of their populations. Where they occur at high numbers, and hence their effects on biodiversity are still of crucial importance, the persecution of these species should be avoided and their natural habitats preserved. In areas with high conservation value, but where these species occur at low densities, management efforts should aim to increase their density. In areas of high commercial value, managers ideally should consider changing prioritization of the area to high conservation value by purchasing the land or obtaining conservation easements. In situations with high commercial value and demonstrable low conservation concern, small mammals could be reduced humanely.     

An evaluation of field and non-invasive genetic methods to estimate brown bear (Ursus arctos) population size

Estimates of population size and density are essential for successful management and conservation of any species. Although there are a variety of methods available for estimating abundance and density of populations, most studies rely on only one estimator and very few studies have compared and critically evaluated the adequacy and the cost of these methods. We used the brown bear (Ursus arctos) in south-central Sweden to compare the performance of three different methods of estimating population size, including methods based on conventional field data as well as on non-invasive genetic data. The method based on observations of females with cubs underestimated the true population size, as the estimates were below the number of unique genotypes determined from faecal data inside the study area. The best traditional method was based on observations of bears from a helicopter. The genetic method using the closed population MARK estimator, as recommended in a previous study, seemed to perform the best. We conclude that approximately 223 (188-282) bears were present in our 7328 km² study area during 2001 and 2002 and suggest that this hunted brown bear population has been relatively stable for about ten years. The non-invasive genetic method was less expensive than the most reliable traditional field method (a CMR method based on observations of bears from a helicopter), and preferable from an ethical point of view. We recommend that future studies using non-invasive genetic methods based on collected faecal samples should aim at collecting 2.5-3 times the number of faecal samples as the “assumed” number of animals.     

THE FIRST TWENTY-ONE YEARS OF VETERINARY DIAGNOSTIC ULTRASOUND

The veterinary literature of 1966–1986 was searched for articles and books related to the use of diagnostic ultrasound in animals. There were 492 references, categorized as follows: general, 30; small animal applications, 169; large animal applications, 248; blood pressure measurement, 23; ultrasound-guided biopsy, 4; miscellaneous, 18.     

The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal

Scrapie and bovine spongiform encephalopathy (BSE) are major global concerns and the emergence of variant Creutzfeldt-Jakob disease (vCJD) has caused turmoil for blood transfusion services and hospitals worldwide. Recent reports of iatrogenic CJD (iCJD) cases following blood transfusions from Transmissible Spongiform Encephalopathies (TSE)-infected donors have fuelled this concern. Major diagnostic tests for BSE and scrapie are conducted post-mortem from animals in late stages of the disease. Although the lymphoreticular system is involved in the earlier pathogenesis of some forms of sheep scrapie and vCJD, which presents great opportunity for diagnostic development, other TSE diseases (some strains of scrapie, sporadic CJD (sCJD) and bovine BSE) do not present such a diagnostic opportunity. Thus, there is an urgent need for pre-mortem tests that differentiate between healthy and diseased individuals at early stages of illness, in accessible samples such as blood and urine using less invasive procedures. This review reports on the current state of progress in the development and use of prion and non-prion biomarkers in the diagnosis of TSE diseases. Some of these efforts have concentrated on improving the sensitivity of PrPSc detection to allow in vivo diagnosis at low abundances of PrPSc whilst others have sought to identify non-prion protein biomarkers of TSE disease, many of which are still at early stages of development. In this review we comment upon the limitations of prion based tests and review current research on the development of tests for TSE that rely on non-prion disease markers in body fluids that may allow preclinical disease diagnosis.